AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
2401
DELISTED
Intersect ENT, Inc
XENT
| $737K | ﹤0.01% |
29,600
| – | – |
|
|
AGEN
2402
Agenus
AGEN
$255M
| $736K | ﹤0.01% |
9,212
| – | – |
|
|
TVRD
2403
Tvardi Therapeutics
TVRD
$23.8M
| $735K | ﹤0.01% |
1,267
+59
| +5% | +$41.4K |
|
2404
UroGen Pharma
URGN
$2.02B
| $731K | ﹤0.01% |
21,900
| – | – |
|
|
ATRS
2405
DELISTED
Antares Pharma, Inc.
ATRS
| $719K | ﹤0.01% |
153,000
| – | – |
|
2406
OraSure Technologies
OSUR
$273M
| $718K | ﹤0.01% |
89,364
+424
| +0.5% | +$3.43K |
|
|
DVAX
2407
DELISTED
Dynavax Technologies
DVAX
| $715K | ﹤0.01% |
125,020
| – | – |
|
2408
Liberty Media Series A
FWONA
$22.6B
| $715K | ﹤0.01% |
17,052
+8,774
| +106% | +$344K |
|
2409
Myers Industries
MYE
$1.23B
| $712K | ﹤0.01% |
42,700
-2,950
| -6% | -$49.1K |
|
2410
Puma Biotechnology
PBYI
$407M
| $704K | ﹤0.01% |
80,500
| – | – |
|
|
RVI
2411
DELISTED
Retail Value Inc. Common Shares
RVI
| $704K | ﹤0.01% |
208,465
+10,895
| +6% | +$36.5K |
|
2412
MacroGenics
MGNX
$254M
| $702K | ﹤0.01% |
64,500
| – | – |
|
2413
Schneider National
SNDR
$6.44B
| $697K | ﹤0.01% |
31,950
+2,900
| +10% | +$65.3K |
|
2414
Horizon Bancorp
HBNC
$1.05B
| $695K | ﹤0.01% |
36,575
| – | – |
|
|
CCRN
2415
DELISTED
Cross Country Healthcare
CCRN
| $692K | ﹤0.01% |
59,545
+300
| +0.5% | +$3.39K |
|
|
CWEN.A
2416
DELISTED
Clearway Energy Class A
CWEN.A
| $692K | ﹤0.01% |
36,200
| – | – |
|
|
DO
2417
DELISTED
Diamond Offshore Drilling
DO
| $690K | ﹤0.01% |
95,967
-12,850
| -12% | -$74.7K |
|
2418
Option Care Health
OPCH
$3.42B
| $689K | ﹤0.01% |
46,175
+1,900
| +4% | +$25.7K |
|
2419
Teekay
TK
$974M
| $687K | ﹤0.01% |
129,100
-6,100
| -5% | -$30.2K |
|
2420
Phibro Animal Health
PAHC
$1.43B
| $683K | ﹤0.01% |
27,500
+100
| +0.4% | +$2.32K |
|
|
AUD
2421
DELISTED
Audacy, Inc.
AUD
| $681K | ﹤0.01% |
146,700
| – | – |
|
2422
QCR Holdings
QCRH
$1.65B
| $680K | ﹤0.01% |
15,500
+3,700
| +31% | +$151K |
|
2423
Gogo Inc
GOGO
$540M
| $679K | ﹤0.01% |
106,100
-13,200
| -11% | -$76.8K |
|
|
GRP.U
2424
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $676K | ﹤0.01% |
13,336
+1,367
| +11% | +$68.8K |
|
2425
Beyond Meat
BYND
$283M
| $673K | ﹤0.01% |
8,900
+5,936
| +200% | +$551K |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.